{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:07:56Z","timestamp":1763705276989,"version":"3.41.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bpsc.2017.03.007","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T01:15:20Z","timestamp":1489540520000},"page":"454-462","source":"Crossref","is-referenced-by-count":10,"title":["Abnormal Trajectory of Intracortical Myelination in Schizophrenia Implicates White Matter in Disease Pathophysiology and the Therapeutic Mechanism of Action of Antipsychotics"],"prefix":"10.1016","volume":"3","author":[{"given":"Todd A.","family":"Tishler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Bartzokis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika P.","family":"Raven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mher","family":"Khanoyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra J.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan H.","family":"Pyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Pablo","family":"Villablanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori L.","family":"Altshuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie R.","family":"Casaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth L.","family":"Subotnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith H.","family":"Nuechterlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin M.","family":"Ellingson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpsc.2017.03.007_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2012.04.006","article-title":"Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination","volume":"138","author":"Zhang","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1471-4159.2012.07883.x","article-title":"Quetiapine prevents oligodendrocyte and myelin loss and promotes maturation of oligodendrocyte progenitors in the hippocampus of global cerebral ischemia mice","volume":"123","author":"Bi","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.bpsc.2017.03.007_bib3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neuroscience.2011.10.051","article-title":"Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL\/6 mice","volume":"202","author":"Chandran","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.bpsc.2017.03.007_bib4","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.pnpbp.2011.07.011","article-title":"Olanzapine stimulates proliferation but inhibits differentiation in rat oligodendrocyte precursor cell cultures","volume":"35","author":"Kimoto","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.schres.2010.02.1068","article-title":"Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain","volume":"119","author":"Wang","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib6","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1185\/03007995.2013.821973","article-title":"Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole","volume":"29","author":"Potkin","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bpsc.2017.03.007_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1017\/S1461145712001095","article-title":"Improving myelin\/oligodendrocyte-related dysfunction: A new mechanism of antipsychotics in the treatment of schizophrenia?","volume":"16","author":"Ren","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bpsc.2017.03.007_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-3223(99)00113-4","article-title":"Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure","volume":"46","author":"Selemon","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.biopsych.2007.08.018","article-title":"Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys","volume":"63","author":"Konopaske","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.21822","article-title":"Evidence for disruption of sphingolipid metabolism in schizophrenia","volume":"87","author":"Narayan","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.schres.2009.06.014","article-title":"In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia","volume":"113","author":"Bartzokis","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib12","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.2741\/3881","article-title":"Neuroglialpharmacology: White matter pathophysiologies and psychiatric treatments","volume":"16","author":"Bartzokis","year":"2011","journal-title":"Front Biosci"},{"key":"10.1016\/j.bpsc.2017.03.007_bib13","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/npp.2013.288","article-title":"White matter changes associated with antipsychotic treatment in first-episode psychosis","volume":"39","author":"Szeszko","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpsc.2017.03.007_bib14","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1017\/S0033291713000238","article-title":"White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment","volume":"43","author":"Wang","year":"2013","journal-title":"Psychol Med"},{"key":"10.1016\/j.bpsc.2017.03.007_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jpsychires.2010.07.007","article-title":"Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: A DTI-tractography study","volume":"45","author":"Luck","year":"2011","journal-title":"J Psychiatr Res"},{"issue":"Pt 1","key":"10.1016\/j.bpsc.2017.03.007_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/brain\/awt310","article-title":"White matter integrity as a predictor of response to treatment in first episode psychosis","volume":"137","author":"Reis Marques","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.bpsc.2017.03.007_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S1461145707007730","article-title":"Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia","volume":"11","author":"Garver","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bpsc.2017.03.007_bib18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.biopsych.2011.05.017","article-title":"Progressive brain change in schizophrenia: A prospective longitudinal study of first-episode schizophrenia","volume":"70","author":"Andreasen","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia","volume":"68","author":"Ho","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1176\/appi.ajp.2013.12050674","article-title":"Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: A prospective longitudinal MRI study","volume":"170","author":"Andreasen","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.schres.2005.07.031","article-title":"Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia","volume":"80","author":"Molina","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.schres.2005.10.019","article-title":"Risperidone in first-episode psychosis: A longitudinal, exploratory voxel-based morphometric study","volume":"82","author":"Girgis","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/schbul\/sbq126","article-title":"Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia","volume":"38","author":"Szeszko","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bpsc.2017.03.007_bib24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1017\/S1461145713001739","article-title":"Amygdalohippocampal neuroplastic changes following neuroleptic treatment with quetiapine in first-episode schizophrenia","volume":"17","author":"Poeppl","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bpsc.2017.03.007_bib25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/cercor\/bhn152","article-title":"Time-lapse mapping of cortical changes in schizophrenia with different treatments","volume":"19","author":"Thompson","year":"2008","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.bpsc.2017.03.007_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.biopsych.2015.02.008","article-title":"The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: Does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies","volume":"78","author":"Vita","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2012.06.036","article-title":"Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia","volume":"140","author":"Bartzokis","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/jamapsychiatry.2015.0270","article-title":"Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia. A randomized clinical trial","volume":"72","author":"Subotnik","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/appi.ajp.2010.09010087","article-title":"Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia","volume":"168","author":"Subotnik","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1993.01820170047006","article-title":"Time course and biologic correlates of treatment response in first-episode schizophrenia","volume":"50","author":"Lieberman","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","article-title":"Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder","volume":"161","author":"Robinson","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.psychres.2004.04.018","article-title":"Classifying episodes in schizophrenia and bipolar disorder: Criteria for relapse and remission applied to recent-onset samples","volume":"144","author":"Nuechterlein","year":"2006","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib34","first-page":"487","article-title":"Longitudinal study of brain morphology in first episode schizophrenia","volume":"49","author":"Lieberman","year":"2001"},{"key":"10.1016\/j.bpsc.2017.03.007_bib35","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0006-3223(01)01303-8","article-title":"The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches","volume":"50","author":"Lieberman","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib36","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.4088\/JCP.1006e14","article-title":"Neurobiology and the natural history of schizophrenia","volume":"67","author":"Lieberman","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib37","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.euroneuro.2013.04.010","article-title":"Antipsychotic response in first-episode schizophrenia: Efficacy of high doses and switching","volume":"23","author":"Agid","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bpsc.2017.03.007_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/JCP.0b013e31827bfcc1","article-title":"Comparison of treatment response in second-episode versus first-episode schizophrenia","volume":"33","author":"Emsley","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.bpsc.2017.03.007_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archpsyc.1994.03950060041004","article-title":"Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood","volume":"51","author":"Benes","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib40","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0893-133X(02)00364-0","article-title":"Schizophrenia: Breakdown in the well-regulated lifelong process of brain development and maturation","volume":"27","author":"Bartzokis","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpsc.2017.03.007_bib41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archpsyc.60.5.443","article-title":"White matter changes in schizophrenia: Evidence for myelin-related dysfunction","volume":"60","author":"Davis","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2003.08.001","article-title":"Quadratic trajectories of brain myelin content: Unifying construct for neuropsychiatric disorders","volume":"25","author":"Bartzokis","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bpsc.2017.03.007_bib43","doi-asserted-by":"crossref","first-page":"16480","DOI":"10.1073\/pnas.1117943109","article-title":"Prolonged myelination in human neocortical evolution","volume":"109","author":"Miller","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpsc.2017.03.007_bib44","series-title":"Clinical Neurology of Aging","first-page":"3","article-title":"Neuroanatomical and neuropathological changes during aging and dementia","author":"Kemper","year":"1994"},{"key":"10.1016\/j.bpsc.2017.03.007_bib45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archpsyc.58.5.461","article-title":"Age-related changes in frontal and temporal lobe volumes in men: A magnetic resonance imaging study","volume":"58","author":"Bartzokis","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib46","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.neuropharm.2012.01.015","article-title":"Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments","volume":"62","author":"Bartzokis","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bpsc.2017.03.007_bib47","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0006-3223(02)01835-8","article-title":"Dysregulated brain development in adult men with schizophrenia: A magnetic resonance imaging study","volume":"53","author":"Bartzokis","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2007.04.014","article-title":"Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders","volume":"94","author":"Vostrikov","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib49","first-page":"174689","article-title":"Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders","volume":"2011","author":"Vostrikov","year":"2011","journal-title":"Schizophr Res Treat"},{"key":"10.1016\/j.bpsc.2017.03.007_bib50","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1023\/A:1020981510759","article-title":"Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia","volume":"27","author":"Hof","year":"2002","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(03)00181-6","article-title":"Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium","volume":"67","author":"Uranova","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib52","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archpsyc.60.6.585","article-title":"Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia","volume":"60","author":"Ho","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib53","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1176\/ajp.2007.164.7.1082","article-title":"Volumetric white matter abnormalities in first-episode schizophrenia: A longitudinal, tensor-based morphometry study","volume":"164","author":"Whitford","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.schres.2009.09.009","article-title":"Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophrenia","volume":"115","author":"Cocchi","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib55","first-page":"5","article-title":"Biological underpinnings of treatment resistance in schizophrenia: An hypothesis","volume":"37","author":"Bartzokis","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.bpsc.2017.03.007_bib56","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1176\/appi.ajp.162.6.1229-a","article-title":"Reduced intracortical myelination in schizophrenia","volume":"162","author":"Bartzokis","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib57","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0022-2275(20)39619-X","article-title":"Lipid composition of the normal human brain: Gray matter, white matter, and myelin","volume":"6","author":"O\u2019Brien","year":"1965","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/B978-0-12-024910-7.50013-0","article-title":"Lipids in the nervous system of different species as a function of age: Brain, spinal cord, peripheral nerve, purified whole cell preparations, and subcellular particulates: Regulatory mechanisms and membrane structure","volume":"10","author":"Rouser","year":"1972","journal-title":"Adv Lipid Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib59","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"Saher","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bpsc.2017.03.007_bib60","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mrm.1910200210","article-title":"Cholesterol of myelin is the determinant of gray-white contrast in MRI of brain","volume":"20","author":"Koenig","year":"1991","journal-title":"Magn Reson Med"},{"year":"1989","series-title":"Magnetic Resonance of Myelin, Myelination, and Myelin Disorders","author":"Valk","key":"10.1016\/j.bpsc.2017.03.007_bib61"},{"key":"10.1016\/j.bpsc.2017.03.007_bib62","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF00340123","article-title":"MR imaging of the various stages of normal myelination during the first year of life","volume":"31","author":"van der Knaap","year":"1990","journal-title":"Neuroradiology"},{"key":"10.1016\/j.bpsc.2017.03.007_bib63","first-page":"447","article-title":"Formation, maturation, and disorders of white matter","volume":"13","author":"Barkovich","year":"1992","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.bpsc.2017.03.007_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-0270(96)00148-3","article-title":"T2 relaxation time as a marker of brain myelination: Experimental MR study in two neonatal animal models","volume":"72","author":"Miot-Noirault","year":"1997","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.bpsc.2017.03.007_bib65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.schres.2009.09.028","article-title":"Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder","volume":"115","author":"Beasley","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00401-008-0430-y","article-title":"Stereologic investigation of the posterior part of the hippocampus in schizophrenia","volume":"117","author":"Schmitt","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bpsc.2017.03.007_bib67","first-page":"325789","article-title":"Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study","volume":"2011","author":"Uranova","year":"2011","journal-title":"Schizophr Res Treat"},{"year":"1919","series-title":"Dementia Praecox and Paraphenia","author":"Kraepelin","key":"10.1016\/j.bpsc.2017.03.007_bib68"},{"issue":"suppl 2","key":"10.1016\/j.bpsc.2017.03.007_bib69","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/schbul\/sbr084","article-title":"Neurocognitive predictors of work outcome in recent-onset schizophrenia","volume":"37","author":"Nuechterlein","year":"2011","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bpsc.2017.03.007_bib70","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2975\/31.4.2008.340.349","article-title":"Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment","volume":"31","author":"Nuechterlein","year":"2008","journal-title":"Psychiatr Rehabil J"},{"key":"10.1016\/j.bpsc.2017.03.007_bib71","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/schbul\/18.3.387","article-title":"Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress","volume":"18","author":"Nuechterlein","year":"1992","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bpsc.2017.03.007_bib72","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-1781(98)00038-9","article-title":"Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I\/P)","volume":"79","author":"Ventura","year":"1998","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2007.10.026","article-title":"Age-associated differences in cognitive performance in older community dwelling schizophrenia patients: Differential sensitivity of clinical neuropsychological and experimental information processing tests","volume":"106","author":"Bowie","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsc.2017.03.007_bib74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-3223(98)00273-X","article-title":"Cognitive decline in late-life schizophrenia: A longitudinal study of geriatric chronically hospitalized patients","volume":"45","author":"Harvey","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib75","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archpsyc.1995.03950220015005","article-title":"Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17","volume":"52","author":"Selemon","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpsc.2017.03.007_bib76","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/(SICI)1096-9861(19980316)392:3<402::AID-CNE9>3.0.CO;2-5","article-title":"Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three-dimensional, stereologic counting method","volume":"392","author":"Selemon","year":"1998","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bpsc.2017.03.007_bib77","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1073\/pnas.91.10.4353","article-title":"A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex","volume":"91","author":"Lidow","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpsc.2017.03.007_bib78","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0022-3565(24)37099-5","article-title":"Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: Effects of chronic treatment with typical and atypical antipsychotic drugs","volume":"283","author":"Lidow","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bpsc.2017.03.007_bib79","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3371\/CSRP.4.1.5","article-title":"Dopamine D2 receptors as treatment targets in schizophrenia","volume":"4","author":"Seeman","year":"2010","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"10.1016\/j.bpsc.2017.03.007_bib80","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bpsc.2017.03.007_bib81","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bpsc.2017.03.007_bib82","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/glia.21122","article-title":"GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo","volume":"59","author":"Azim","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.bpsc.2017.03.007_bib83","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1523\/JNEUROSCI.0150-08.2008","article-title":"Constitutively active Akt induces enhanced myelination in the CNS","volume":"28","author":"Flores","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.bpsc.2017.03.007_bib84","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1523\/JNEUROSCI.0232-09.2009","article-title":"Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination","volume":"29","author":"Narayanan","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.bpsc.2017.03.007_bib85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14737175.9.1.9","article-title":"Use of long-acting risperidone in psychiatric disorders: Focus on efficacy, safety and cost-effectiveness","volume":"9","author":"Keith","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.bpsc.2017.03.007_bib86","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cne.902100309","article-title":"Postnatal changes in the number of astrocytes, oligodendrocytes, and microglia in the visual cortex (area 17) of the macaque monkey: A stereological analysis in normal and monocularly deprived animals","volume":"210","author":"O\u2019Kusky","year":"1982","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bpsc.2017.03.007_bib87","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tics.2009.12.002","article-title":"Neural synchrony and the development of cortical networks","volume":"14","author":"Uhlhaas","year":"2010","journal-title":"Trends Cogn Sci"},{"key":"10.1016\/j.bpsc.2017.03.007_bib88","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cne.901720205","article-title":"Response of the three main types of glial cells of cortex and corpus callosum in rats handled during suckling or exposed to enriched, control and impoverished environments following weaning","volume":"172","author":"Szeligo","year":"1977","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bpsc.2017.03.007_bib89","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/neu.480030105","article-title":"Effects of environmental enrichment and impoverishment on rat cerebral cortex","volume":"3","author":"Diamond","year":"1972","journal-title":"J Neurobiol"},{"key":"10.1016\/j.bpsc.2017.03.007_bib90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cne.901180202","article-title":"A note on myeloarchitectonics","volume":"118","author":"Braitenberg","year":"1962","journal-title":"J Comp Neurol"}],"container-title":["Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451902217300587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451902217300587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T20:54:29Z","timestamp":1750107269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451902217300587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2451902217300587"],"URL":"https:\/\/doi.org\/10.1016\/j.bpsc.2017.03.007","relation":{},"ISSN":["2451-9022"],"issn-type":[{"type":"print","value":"2451-9022"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}